Infor Pairs with NextGate
to Boost Matching AccuracyPosted at - 09:32 AM on Tue, Jul 02, 2013

Share this:
Infor Pairs with NextGate <br>to Boost Matching Accuracy

Resolve patient and provider identities across disparate systems now with superior matching accuracy of Infor Healthcare with NextGate integration.

Infor Cloverleaf is now available with NextGate, a leading provider of enterprise master patient index (EMPI) and identity management solutions. The NextGate EMPI and Provider Registry application also help eliminate duplicate records that hinder effective data sharing.

MatchMetrix is NextGate's master data management platform upon which domain-specific registries, including EMPI and Provider Registry, are created. The flexible and integrated technology platform resolves identity matching uncertainties to enable more accurate exchange of healthcare information in support of the patient-centric, meaningful use, and interoperable initiatives, including ACO and HIE.

"Being selected by Infor, a company that is highly respected in the healthcare industry, is a great validation of the advanced and sophisticated capabilities of our MatchMetrix technology," said Andy Aroditis, president and CEO of NextGate. "Together, our solutions provide the infrastructure required to integrate critical technology that helps our customer organizations maintain accurate views of patient and provider data across disparate systems to coordinate care and reduce operational inefficiencies." 

The Infor Cloverleaf Integration and Information Exchange Suite modernizes the exchange of healthcare data within an organization, with partners, and across communities of care.  The suite delivers a secure, standards-based infrastructure that integrates a wide variety of clinical document types, as well as the widely deployed Infor Lawson Financial Management and Supply Chain Management systems.  

Learn more.

Share this:
blog comments powered by Disqus
Return to top of page.
Specialized by industry.
Engineered for speed.
© Copyright 2015. Infor. All rights reserved.